Industry News
UNSW spin-off Biosignal to list in reverse takeover
Biosignal, a spin-off from the University of NSW, is to list on the ASX in late March through a reverse takeover of CTI Communications (ASX:CTC), a telecommunications services company. [ + ]
Public to get another say on xenotransplantation
The National Health and Medical Research Council has kicked off a second round of public comment on its draft guidelines for xenotransplantation research, and will run a series of community consultation meetings in capital cities in February. [ + ]
Xeno virus no problem: researcher
A new US finding, that transplanted human cells can form pig-human hybrid cells in foetal pigs, does not present a new hazard for transplants of humanised pig organs or cells into humans, according to a leading Melbourne xenotransplantation researcher. [ + ]
Patch vaccines may increase autoimmune disease risk
Australian researchers have shown in a mouse model that a bacterial toxin used as an immune-stimulating agent in some vaccines may increase the risk of developing autoimmune disease, where the immune system reacts against the body's own proteins. [ + ]
pSivida to trade on German exchanges
Perth-based nanotech company pSivida (ASX:PSD) will soon commence trading on the German stock exchanges in Berlin, Munich and Stuttgart after meeting all listing requirements, the company has announced. [ + ]
AustCancer touts US, UK opportunities
As Australian Cancer Technology heads into Phase II clinical trials for its Pentrix anti-cancer vaccine, the company says it is evaluating a couple of new opportunities to expand its oncology drug development pipeline from the US and UK. [ + ]
Intel searches for cancer's fingerprints
They've been using it for years to check for physical faults in semiconductor manufacturing, but researchers at computer chip maker Intel are excited about the potential new uses for a spectroscopic technique they hope could revolutionise the testing of samples for contaminants and disease. [ + ]
Double pulsar find to test relativity
An international team of scientists working in the UK, Australia, Italy and the USA has made an astronomical discovery that has major implications for testing Einstein's general theory of relativity.
[ + ]Gradipore to acquire US plasma business
Gradipore (ASX:GDP) has agreed to acquire a plasma therapeutics business in the US for AUD$6.42 million, providing it with a source of plasma for the development of a therapeutic product using its separations technology to purify plasma components. [ + ]
Lancet archive goes online
A project to store every issue of The Lancet medical journal in a searchable database has been completed, making the digital archive a major resource for medical researchers and historians.
[ + ]Rockeby signs HK distributor
Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau. [ + ]
NZ's Encoate to launch novel pest control method
New Zealand biocontrol company Encoate will launch the latest wrinkle in pest control next month: shrink-wrapped bacteria to control pasture and lawn grubs. [ + ]
Ellex awarded $3.3m R&D grant
Adelaide company Ellex Medical Lasers (ASX:ELX) has been awarded a AUD$3.3 million R&D Start grant from the federal government to develop a new ophthalmic laser device. [ + ]
pSivida to focus on cancer diagnostics
Perth-based nanotechnology company pSivida (ASX: PSD) has selected cancer diagnostics as the first target area for its in vivo immunodiagnostic system. [ + ]
C3 gets nod for entry into European market
Perth company Clinical Cell Culture (C3) has received approval for its CellSpray and CellSpray XP products in Germany and Austria, paving the way for entry into the European market. [ + ]